About Tissuemed
Tissuemed is a company based in Leeds (United Kingdom) founded in 1985 was acquired by Becton Dickinson in December 2021.. Tissuemed has raised $12.69 million across 6 funding rounds from investors including Gov.uk, BD and 3i Group. The company has 19 employees as of March 31, 2022. Tissuemed operates in a competitive market with competitors including CereVasc, IRRAS, Longeviti, Aqueduct Critical Care and Aqueduct Neurosciences, among others.
- Headquarter Leeds, United Kingdom
- Employees 19 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tissuemed Limited
- Date of Incorporation 04 Apr, 1985
- Jurisdiction WEST YORKSHIRE
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.69 M (USD)
in 6 rounds
-
Latest Funding Round
$52.94 K (USD), Grant
Nov 30, 2015
-
Investors
Gov.uk
& 5 more
-
Employee Count
19
as on Mar 31, 2022
-
Acquired by
Becton Dickinson
(Dec 09, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Tissuemed
Tissuemed has successfully raised a total of $12.69M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $52.94 thousand completed in November 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $52,942
-
First Round
First Round
(01 May 1999)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2015 | Amount | Grant - Tissuemed | Valuation |
investors |
|
| Jul, 2015 | Amount | Grant - Tissuemed | Valuation |
investors |
|
| Jun, 2015 | Amount | Grant - Tissuemed | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tissuemed
Tissuemed has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, BD and 3i Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Private equity firm focused on mid-market businesses
|
Founded Year | Domain | Location | |
|
Global private equity and venture capital investments in B2B Tech & Services companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tissuemed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tissuemed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tissuemed Comparisons
Competitors of Tissuemed
Tissuemed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CereVasc, IRRAS, Longeviti, Aqueduct Critical Care and Aqueduct Neurosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
eShunt device is developed for communicating hydrocephalus treatment.
|
|
| domain | founded_year | HQ Location |
Provider of devices for fluid control and management after surgery
|
|
| domain | founded_year | HQ Location |
Implantable neurosurgical devices are developed for cranial defect correction.
|
|
| domain | founded_year | HQ Location |
Novel products to manage Cerebral Spinal Fluid (CSF) pressure
|
|
| domain | founded_year | HQ Location |
Develops implantable shunts to treat hydrocephalus.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tissuemed
Frequently Asked Questions about Tissuemed
When was Tissuemed founded?
Tissuemed was founded in 1985 and raised its 1st funding round 14 years after it was founded.
Where is Tissuemed located?
Tissuemed is headquartered in Leeds, United Kingdom. It is registered at Leeds, England, United Kingdom.
Is Tissuemed a funded company?
Tissuemed is a funded company, having raised a total of $12.69M across 6 funding rounds to date.
How many employees does Tissuemed have?
As of Mar 31, 2022, the latest employee count at Tissuemed is 19.
What does Tissuemed do?
Tissuemed develops and markets synthetic, self-adhesive, bioadhesive films to prevent air, blood, CSF and other fluid leaks encountered in surgery. All products incorporate a patented polymer on one side that bonds to tissue surfaces. The other surface is non-adhesive, providing favourable structural characteristics, ease of handling and potentially preventing post-surgical adhesions. TissuePatch films are ultimately resorbable and, reassuringly, based on polymers commonly used in other implants. Flagship product TissuePatchDural is used for prevention of CSF leaks in Neuro and Spinal surgery when the Dura Mater has been breached. Tissuemed has been granted regulatory approval of its TissuePatch range of ultra-thin surgical sealant films by Chinese FDA.
Who are the top competitors of Tissuemed?
Tissuemed's top competitors include CereVasc, Aqueduct Critical Care and IRRAS.
Who are Tissuemed's investors?
Tissuemed has 6 investors. Key investors include Gov.uk, BD, 3i Group, European Union, and EIC Fund.